Paulness, they have a technology that is very unique. When we gain more independent verification from the tests they are doing & have the data necessary to go into clinical trials, we will see drastic PPS increases. India is another variable, if the human trials go well, that data is more ammunition for here.
I feel that Malcolm knows when the time is right to start pulling the trigger on financing. I think they can draw incrementaly, as the need it. That would keep the carrying costs down and let the PPS rise for less & less dilution. That's how it's normally done on larger amounts of money, it's like a line of credit.
Alot of people aren't going to forgive themselves for letting these cheaper share prices go. It happened a few times the past year, these bounces we have seen. Last time it was ~$.38 and no sooner back into the ~$.80 + range. The difference now is we are nearly prepared to give the world cures & new hope. The media & press will help pump us up even more.
Last chance.